Discovery of Dengue Virus NS4B Inhibitors

登革热病毒 生物 病毒学 登革热 病毒血症 病毒复制 复制子 体内 药物发现 病毒 生物化学 基因 遗传学 质粒
作者
Qing-Yin Wang,Hongping Dong,Bin Zou,Ratna Karuna,Kah Fei Wan,Jing Zou,Agatha Susila,Andy Yip,Chao Shan,Kim Long Yeo,Haoying Xu,Mei Ding,Wai Ling Chan,Feng Gu,Peck Gee Seah,Wei Liu,Suresh B. Lakshminarayana,CongBao Kang,Julien Lescar,Francesca Blasco
出处
期刊:Journal of Virology [American Society for Microbiology]
卷期号:89 (16): 8233-8244 被引量:113
标识
DOI:10.1128/jvi.00855-15
摘要

ABSTRACT The four serotypes of dengue virus (DENV-1 to -4) represent the most prevalent mosquito-borne viral pathogens in humans. No clinically approved vaccine or antiviral is currently available for DENV. Here we report a spiropyrazolopyridone compound that potently inhibits DENV both in vitro and in vivo . The inhibitor was identified through screening of a 1.8-million-compound library by using a DENV-2 replicon assay. The compound selectively inhibits DENV-2 and -3 (50% effective concentration [EC 50 ], 10 to 80 nM) but not DENV-1 and -4 (EC 50 , >20 μM). Resistance analysis showed that a mutation at amino acid 63 of DENV-2 NS4B (a nonenzymatic transmembrane protein and a component of the viral replication complex) could confer resistance to compound inhibition. Genetic studies demonstrate that variations at amino acid 63 of viral NS4B are responsible for the selective inhibition of DENV-2 and -3. Medicinal chemistry improved the physicochemical properties of the initial “hit” (compound 1), leading to compound 14a, which has good in vivo pharmacokinetics. Treatment of DENV-2-infected AG129 mice with compound 14a suppressed viremia, even when the treatment started after viral infection. The results have proven the concept that inhibitors of NS4B could potentially be developed for clinical treatment of DENV infection. Compound 14a represents a potential preclinical candidate for treatment of DENV-2- and -3-infected patients. IMPORTANCE Dengue virus (DENV) threatens up to 2.5 billion people and is now spreading in many regions in the world where it was not previously endemic. While there are several promising vaccine candidates in clinical trials, approved vaccines or antivirals are not yet available. Here we describe the identification and characterization of a spiropyrazolopyridone as a novel inhibitor of DENV by targeting the viral NS4B protein. The compound potently inhibits two of the four serotypes of DENV (DENV-2 and -3) both in vitro and in vivo . Our results validate, for the first time, that NS4B inhibitors could potentially be developed for antiviral therapy for treatment of DENV infection in humans.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
789完成签到,获得积分10
刚刚
小桃子完成签到,获得积分10
刚刚
东郭乾完成签到 ,获得积分10
1秒前
1秒前
林文完成签到,获得积分20
2秒前
JG发布了新的文献求助10
2秒前
2秒前
ABC完成签到,获得积分10
2秒前
脂包肉发布了新的文献求助10
2秒前
2秒前
3秒前
余喆完成签到,获得积分10
3秒前
h11的应助被呼呼呼呼采纳,获得10
3秒前
小二郎的应助被神勇的女孩采纳,获得10
3秒前
Ava的应助被萨克斯采纳,获得10
3秒前
coolboy111发布了新的文献求助10
3秒前
小王完成签到,获得积分10
3秒前
思源的应助被明芷蝶采纳,获得10
3秒前
4秒前
4秒前
4秒前
坚强的夏真完成签到 ,获得积分10
4秒前
4秒前
丁1完成签到 ,获得积分10
5秒前
5秒前
我是谁的应助被隶书采纳,获得60
6秒前
李健的小迷弟的应助被顾顾采纳,获得10
6秒前
不吃鱼发布了新的文献求助10
6秒前
野战星完成签到 ,获得积分10
6秒前
7秒前
李健的应助被热心万天采纳,获得10
7秒前
HDS发布了新的文献求助10
7秒前
梦二完成签到,获得积分10
7秒前
哈基米发布了新的文献求助10
7秒前
7秒前
wanci的应助被yu采纳,获得30
7秒前
Lucky0326完成签到,获得积分10
8秒前
蓝蜗牛发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159929
求助须知:如何正确求助?哪些是违规求助? 9555266
关于积分的说明 21726335
捐赠科研通 7749807
什么是DOI,文献DOI怎么找? 3427310
关于科研通互助平台的介绍 2552391
邀请新用户注册赠送积分活动 2471654